Converge Bio
Germany
aliveseed
seed
Stage
2024
Founded
2
Investors
About
Converge Bio is a biotechnology company developing novel therapeutics for patients suffering from autoimmune diseases. They focus on targeting specific immune cells to create highly effective and safe treatments.
Explore Converge Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.